Press Release

Histology and Cytology Market to grow with a CAGR of 12.15% through 2028

The increasing prevalence of cancer is expected to drive the Global Histology and Cytology Market growth in the forecast period, 2024-2028.


According to TechSci Research report, “Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global Histology and Cytology Market stood at USD 15.74 Billion in 2022 is anticipated to grow at an impressive rate of 12.15% in the forecast period, 2024-2028. The market for Histology and Cytology devices has witnessed consistent growth over the past decade, primarily driven by factors such as the rising prevalence of cancer, increasing standardization of pathological laboratories, and technological advancements in diagnostic and molecular techniques. The increasing burden of cancer on society is found to be a major threat to developing countries, owing to lower disposable income and dynamic demographics. Cancer has been the leading cause of mortality globally and has resulted in deaths that have accounted for the largest share of mortality.


Moreover, the histology and cytology market has also experienced huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies. According to the Globocan, 2020 report, about 2,206,771 cases of new lung cancer were diagnosed in 2020 around the world, and about 1,796,144 people died because of lung cancer in 2020, globally, which shows a burden of lung cancer. Due to the observations at the cellular level, the companies primarily prefer cytology-based diagnostic methods. Since in the coming decade, companies are focusing on diagnosis at the molecular level, cytology is expected to play a vital role. The increasing cervical cancer cytology test approvals are expected to drive the growth of the studied segment during the forecast period which will further drive the growth of the Global Histology and Cytology Market during the forecast period.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Histology and Cytology Market.”


Similarly, lack of awareness among the public for diagnostic tests and diagnostic accuracy issues with histopathological and cytopathological tests are the major factors restraining the growth of Global histology and cytology market during the forecast period. Also, mislabelled specimens, stringent government rules, complicated procedures associated with histology and cytology along with low cytology tests restrict the growth of Global Histology and Cytology Market during the forecast period.


The Global Histology and Cytology Market is segmented into Type of Examination, Product, Application and company.


Based on the Type of Examination, Global Histology and Cytology market is divided into Histology, Cytology. The cytology segment accounted for the largest revenue share in 2022 and is expected to exhibit a rapid CAGR over the forecast period. This can be attributed to the increasing prevalence of breast cancer so the growing demand for cancer screening is increased along with Due to the observations at the cellular level, the companies primarily prefer cytology-based diagnostic methods. The increasing cervical cancer cytology test approvals are expected to drive the growth of the studied segment during the forecast period. Thus, owing to the above factors during the forecast period, the demand for cervical cancer cytological methods is expected to grow, with more number of companies exploring the method. Moreover, the surge in the number of well-equipped clinical laboratories and favorable reimbursement for cancer screening and laboratory tests have a positive effect on the market growth.


Major companies operating in Global Histology and Cytology Market are:

  • Hologic, Inc.
  • F Hoffmann-La Roche AG.
  • Abbott Laboratories Inc.
  • Becton Dickinson & Co.
  • Danaher Corporation.
  • Merck KGaA.
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation.
  • Trivitron Healthcare.
  • Koninklijke Philips N.V.


In January 2021, Biocare Medical, LLC released ONCORE Pro, a completely automated staining platform for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) applications.

In September 2020, GeneTex, Inc. entered into a partnership with HistoWiz, Inc. for establishing various validated antibodies for immunohistochemistry in the human COVID-19 infected tissues.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“North America region is expected to witness significant growth due to the high incidences of cancer, extensive R&D activities, presence of key players, and established research infrastructure for pathology services. Also, The high rate of product approval and commercialization in the region and driving the growth of the Histology and Cytology market. Additionally, researchers are increasingly evaluating new cytology which is further fueling the growth of the market for histology and cytology in the region. The various launch for efficient screening of tissues and cells for diagnostic purpose is anticipated to propel the market growth over the forecast period and is expected to further boost the global Histology and Cytology market. Also, advancements such as digital pathology solutions and automated tissue processing systems have resulted in faster and more precise processes, which has led to greater adoption of these technologies in North America” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.


“Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type Of Examination (Histology, Cytology), By Product (Instruments and Analysis Software System, Consumable and Reagents), By Application (Drug Discovery & Designing, Clinical Diagnostics, Research), By Region and Competition”,
has evaluated the future growth potential of Global Histology and Cytology Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Histology and Cytology Market.


Contact

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:[email protected]
Website: https://www.techsciresearch.com

Relevant News